-
(S)-(+)-Dimethindene maleate: M2 Assay Guide
2026-09-08
(S)-(+)-Dimethindene maleate is a research reagent for controlled investigation of M2 muscarinic receptor antagonism while monitoring potential histamine H1 activity. It is suited to in vitro and ex vivo pharmacology workflows, but should not be used for clinical, diagnostic, therapeutic, or long-term solution applications.
-
Sorafenib (BAY-43-9006) Cancer Assay Workflows
2026-09-08
Build reproducible Sorafenib assays around RAF/MEK/ERK, RTK, PDGFR, and VEGFR biology rather than relying on a single viability endpoint. This workflow connects ATRX-stratified glioma experiments with antiangiogenic and hepatocellular carcinoma model applications while addressing dosing, formulation, and combination-treatment pitfalls.
-
GnRH Antagonist Design at Position 3
2026-09-07
Samant and colleagues examined how replacing the position-3 residue of degarelix with 3-(2-methoxy-5-pyridyl)-alanine affects GnRH receptor antagonism and duration of action. The D-configured analog retained strong in vitro potency, whereas the L-configured analog was substantially weaker; both compounds were short-acting in the castrated male rat assay, highlighting the importance of stereochemistry and pharmacokinetic behavior in peptide design.
-
Protecting DFCP1–ATGL Mechanistic Readouts
2026-09-07
DFCP1–ATGL signaling offers a powerful model for studying starvation-driven lipid droplet lipolysis, but mechanistic conclusions can be weakened by post-lysis protein degradation. This thought-leadership guide connects the biology of DFCP1 recruitment and retention with practical extraction strategy, EDTA-aware assay design, translational sample handling, and a more disciplined approach to selecting a Protease Inhibitor Cocktail.
-
DOPE Workflows for Delivery and Fungal Lipid Assays
2026-09-05
1,2-Dioleoyl-sn-glycero-3-PE supports endosomal escape in nucleic acid formulations and offers a practical phosphatidylethanolamine probe for fungal developmental assays. This guide connects formulation, rescue experiments, controls, and troubleshooting without confusing established delivery performance with emerging ferroptosis evidence.
-
D-N-Acetylgalactosamine: Protocol and QC Guide
2026-09-04
D-N-Acetylgalactosamine is a high-purity, water- or DMSO-soluble reagent for glycoprotein structure studies, brain heteropolysaccharides analysis, and related glycosylation pathway workflows. It is not appropriate for protocols requiring ethanol solubility or long-term storage of prepared solutions.
-
Sorafenib: A Translational Map from Kinases to Tumors
2026-09-04
Sorafenib (BAY-43-9006) is more than a conventional kinase inhibitor: it is a strategic cancer biology research tool for connecting RAF/MEK/ERK signaling, angiogenesis, tumor proliferation inhibition, and genotype-defined therapeutic response. This article outlines how to use Sorafenib across hepatocellular carcinoma models and ATRX-deficient glioma research while maintaining translational discipline.
-
EdU Imaging Kits (HF594): Workflow Guide
2026-09-03
EdU Imaging Kits (HF594) (SKU K2243) provide a practical method for detecting DNA synthesis during S-phase with fluorescent click chemistry for microscopy or flow cytometry. They are suited to fixed-cell proliferation and cell-cycle workflows, but should not replace live-cell lineage tracking, RNA synthesis assays, or orthogonal tests of viability and mechanism.
-
α-Linolenic Acid: Applied Research Workflows
2026-09-03
Build reproducible ALA experiments for lipid flux, cardiovascular signaling, inflammation, and cancer biology. This workflow emphasizes formulation controls, time-course design, lipidomics, and careful separation of evidence-based applications from hypotheses inspired by recent arachidonic acid research.
-
Calpain, BDNF/TrkB, and Offspring Cognition
2026-09-02
A 2025 Neuropharmacology study identifies excessive calpain activity as a mechanistic link between maternal non-obstetric surgery during pregnancy and later cognitive deficits in rat offspring. Pharmacological calpain inhibition with MDL 28170 partially restored hippocampal synaptic markers, neuronal structure, and behavioral performance, supporting calpain–BDNF/TrkB dysregulation as a target for neuroprotection research.
-
Sodium phosphate dibasic for assay reliability
2026-09-02
This scenario-driven guide explains how Sodium phosphate dibasic (SKU B7293) can support controlled pH conditions in cell-based, biochemical, and aquatic toxicity workflows. It connects formulation details, practical buffer handling, and published toxicity data to help researchers improve assay interpretation without overstating product-specific performance.
-
Prunin Targets the Senecavirus A IRES
2026-09-01
The reference study identifies prunin as an inhibitor of Senecavirus A replication in cell-based and animal models, with evidence pointing to the viral internal ribosome entry site as a mechanistic target. Its layered design connects antiviral activity with IRES-dependent translation and protein-interaction changes, while also highlighting the need for direct-binding, pharmacokinetic, and safety studies.
-
Adiponectin, TLR4 and Cognitive Deficits in Aged Rats
2026-09-01
This reference study shows that adiponectin pretreatment alleviated splenectomy-associated cognitive deficits in aged rats while reducing hippocampal neuroinflammation and oxidative stress. Pharmacological inhibition and activation experiments implicate the TLR4/MyD88/NF-κB pathway, although the findings remain preclinical and require validation beyond the splenectomy model.
-
HSP90 Regulates RNA Foci in Myotonic Dystrophy Type 1
2026-08-31
Johnson et al. used an unbiased RNA-FISH small-molecule screen to identify HSP90 as a regulator of pathogenic DMPK mRNA and CUG-repeat RNA foci in Myotonic Dystrophy type 1. The study further connects HSP90 activity to p-STAT3 in undifferentiated myoblasts while revealing a differentiation-dependent reversal of the response, providing a framework for studying RNA-foci homeostasis rather than only foci reduction.
-
Gut-Brain Cholinergic Signaling in B. fragilis
2026-08-31
Jia et al. identify a vagal gut-brain cholinergic circuit through which Bacteroides fragilis suppresses seizures, linking colonic ChAT-positive cells with antiseizure activity in mice. The combination of microbiome analysis, neural recordings, circuit manipulation, and a pediatric clinical trial provides a mechanistic framework for microbiota-targeted epilepsy research.